Hearing Loss in Neuromyelitis Optica Spectrum Disorder: Case Report and Systematic Review
Journal of Clinical Medicine · 06.01.2026 · 15 (2) · 422
DOI: 10.3390/jcm15020422 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.01.2026. Verfasst von Stefania Kalampokini und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Neurology, AHEPA University Hospital, Aristotle University, 54636 Thessaloniki, Greece. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sudden, non-traumatic hearing loss has been associated with vascular or inflammatory disorders. Hearing loss in Neuromyelitis optica spectrum disorder (NMOSD) is a very rare presentation.
Methods
In this paper, we describe the case of a 58-year-old female patient with aquaporin-4-positive NMOSD exhibiting bilateral tinnitus and right-sided deafness in the context of a relapse. The auditory brainstem responses pointed to a lesion of the right peripheral auditory pathway (cochlea and/or auditory nerve). The patient’s hearing failed to improve after high-dose intravenous steroids; however, it showed slight improvement after plasmapheresis. We also conducted a systematic literature review in databases MEDLINE and Scopus in English, searching for all reported cases of hearing loss in NMOSD.
Results
We included 10 studies reporting 15 cases of NMOSD with hearing loss. The vast majority of patients were female (11 out of 15, 73.3%), with an age range of 26 to 70 years. Hearing loss, ranging from mild to severe, seems more frequent in AQP4-positive cases, and it can even be the presenting symptom. It can present isolated or in combination with tinnitus, ataxia, and/or intractable vomiting. The auditory pathway impairment in NMOSD seems to be localized either centrally, i.e., cochlear nuclei or higher brainstem levels, or peripherally, i.e., in the cochlea or cochlear nerve itself. Intravenous methylprednisolone in high doses, followed by oral tapering, was the most common treatment option, resulting in a gradual improvement.
Conclusions
This paper describes a rare case of peripheral auditory pathway affection in NMOSD, which is an inflammatory astrocytopathy mainly affecting the central nervous system. Early recognition of hearing loss in the context of an NMOSD relapse and subsequent treatment have a crucial impact on the hearing outcome of NMOSD patients. This expands our knowledge of NMOSD as an autoimmune aquaporin-4 channelopathy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Department of Neurology, AHEPA University Hospital, Aristotle University, 54636 Thessaloniki, Greece.
- 1st Academic ENT Department, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
ORCID-Profile: Stefania Kalampokini, Effrosyni Koutsouraki, George Psillas, Martha Spilioti, Vasilios Kimiskidis
Zitieren
APA
Kalampokini, S., Koutsouraki, E., Psillas, G., Karatzioula, E., Kaffe, K., Spilioti, M., & Kimiskidis, V. (2026). Hearing Loss in Neuromyelitis Optica Spectrum Disorder: Case Report and Systematic Review. Journal of Clinical Medicine, 15(2), 422. https://doi.org/10.3390/jcm15020422
Vancouver
Kalampokini S, Koutsouraki E, Psillas G, Karatzioula E, Kaffe K, Spilioti M, et al. Hearing Loss in Neuromyelitis Optica Spectrum Disorder: Case Report and Systematic Review. Journal of Clinical Medicine. 2026;15(2):422. doi:10.3390/jcm15020422
BibTeX
@article{Kalampokini2026,
author = {Kalampokini, Stefania and Koutsouraki, Effrosyni and Psillas, George and Karatzioula, Effrosyni and Kaffe, Korina and Spilioti, Martha and Kimiskidis, Vasilios},
title = {Hearing Loss in Neuromyelitis Optica Spectrum Disorder: Case Report and Systematic Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {2},
pages = {422},
doi = {10.3390/jcm15020422}
}
EUVIMED